Serve AI Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$5M
- Investors
-
7
Serve AI General Information
Description
Developer of an enterprise AI infrastructure platform designed to deliver purpose-built, privately owned decision intelligence. The company's platform provides domain-specific AI models with real-time alerting, full model ownership, and transparent, auditable intelligence, enabling enterprises to surface critical operational insights and hidden opportunities without relying on third-party AI services.
Contact Information
Website
www.serveitup.aiCorporate Office
- 6320 Lamar Avenue
- Suite 200
- Overland Park, KS 66202
- United States
Corporate Office
- 6320 Lamar Avenue
- Suite 200
- Overland Park, KS 66202
- United States
Serve AI Timeline
Serve AI Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 01-Oct-2025 | $5M | Completed | Generating Revenue | ||
| 2. Early Stage VC | 29-Nov-2023 | Completed | Generating Revenue | |||
| 1. Seed Round | 24-May-2023 | $1.1M | $1.1M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Serve AI Patents
Serve AI Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| DE-3773963-D1 | Method for producing mature, human serum albumin. | Inactive | 21-Feb-1986 | ||
| EP-0236210-A1 | Method for the synthesis of mature human serum albumin | Active | 21-Feb-1986 | ||
| EP-0236210-B1 | Method for the synthesis of mature human serum albumin | Inactive | 21-Feb-1986 | ||
| FR-2594845-A1 | Microbiological preparation of the human plasminogen tissue activator (t-pa) and conversion of the enzyme so obtained in its active form | Active | 21-Feb-1986 | ||
| FR-2594845-B1 | Microbiological preparation of the human plasminogen tissue activator (t-pa) and conversion of the enzyme so obtained in its active form | Inactive | 21-Feb-1986 | C12N9/6459 |
Serve AI Signals
Serve AI Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| EMERGING | Growth/Expansion | Minority | ||
| P1 Investments (Oxfordshire) | Venture Capital | Minority | ||
| JAM Fund | Venture Capital | Minority | ||
| Angel (individual) | Minority |
Serve AI FAQs
-
When was Serve AI founded?
Serve AI was founded in 2020.
-
Where is Serve AI headquartered?
Serve AI is headquartered in Overland Park, KS.
-
What is the size of Serve AI?
Serve AI has 21 total employees.
-
What industry is Serve AI in?
Serve AI’s primary industry is Business/Productivity Software.
-
Is Serve AI a private or public company?
Serve AI is a Private company.
-
What is Serve AI’s current revenue?
The current revenue for Serve AI is .
-
How much funding has Serve AI raised over time?
Serve AI has raised $9.2M.
-
Who are Serve AI’s investors?
, EMERGING, P1 Investments (Oxfordshire), JAM Fund, and are 5 of 7 investors who have invested in Serve AI.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process